BioHorizon Health Technology Surveillance Update: February 8, 2010
February 8, 2010 by tim · Leave a Comment
The BioHorizon Health Technology Surveillance Update gives readers a concise, high level overview of the most important emerging health technology developments on a ongoing basis including key FDA approvals, substantive clinical trial results and upcoming events of importance.
First of all, on behalf of the entire BioHorizon staff, let me welcome you to the BioHorizon Health Technology [...]
Wyeth vs. GSK: A Vaccine Showdown?
January 11, 2009 by tim · Leave a Comment
Today Biohorizon will take its first look at two new vaccines that promise to make the prevention of pneumococcal disease far more interesting and complex. Both Wyeth and GSK have advanced emerging pneumococcal conjugate vaccine candidates to the filing stage in either the United States, European Union or both. In an effort to understand and [...]